Thyroxine Levels in Liver Cancer Patients
Author Information
Author(s): A. Alexopoulos, W. Hutchinson, A. Bari, J.J. Keating, P.J. Johnson, R. Williams
Primary Institution: Kings College Hospital School of Medicine and Dentistry
Hypothesis
Whether abnormalities of thyroid binding proteins occur before the diagnosis of hepatocellular carcinoma (HCC).
Conclusion
Patients with hepatocellular carcinoma had significantly higher serum thyroxine levels due to elevated thyroxine binding globulin, even before clinical signs of the disease appeared.
Supporting Evidence
- Serum thyroxine was significantly higher in patients with HCC compared to normal subjects.
- Elevated thyroxine levels were linked to high levels of thyroxine binding globulin.
- TBG levels rose steadily in cirrhotic patients who developed HCC.
Takeaway
This study found that people with liver cancer have higher thyroid hormone levels, which might be one of the first signs of the disease.
Methodology
Serum thyroid hormones and binding proteins were measured in patients with HCC and various control groups, including cirrhosis and other tumors.
Limitations
The study does not establish the clinical utility of TBG levels as a marker for HCC due to overlap with cirrhotic patients.
Participant Demographics
59 patients with HCC (46 males, 13 females) aged 17-74 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website